Renoprotective effects of dulaglutide in patients with T2DM and CKD
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Nephrology"
DOI: 10.1038/s41581-018-0055-x
Abstract: The AWARD-7 trial shows that the glucagon-like peptide 1 (GLP1) receptor agonist dulaglutide, which is not cleared by the kidney, seems to be renoprotective, ameliorates albuminuria and slows estimated glomerular filtration rate decline in patients… read more here.
Keywords: effects dulaglutide; renoprotective effects; t2dm ckd; patients t2dm ... See more keywords
Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.14000
Abstract: Few studies have examined the effects of glucagon‐like peptide‐1 receptor agonist switching, particularly in Japanese patients. Therefore, we aimed to investigate the effects of switching from liraglutide to semaglutide or dulaglutide on blood glucose, body… read more here.
Keywords: liraglutide semaglutide; switching liraglutide; dulaglutide patients; effects switching ... See more keywords